Biobank Clinical Genetics Maastricht (KG01)

Biobank Clinical Genetics Maastricht

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02266615

Acronym

KG01

Enrollment

3600

Registered

2014-10-17

Start date

2014-09-30

Completion date

2035-01-31

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genetic Disease

Brief summary

Collection of coded biomaterial and clinical data with patients consent for future research.

Detailed description

Collection of coded biomaterial and clinical data with patients consent for future research, with the purpose to indentify new gene mutation and prossibilities for treatment in the future.

Interventions

GENETICBiobanking of biomaterial for future genetic research.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* New patients visiting the out patient clinic of the department of Clinical Genetics of the Maastricht University Medical Hospital * Withdrawal of body material for genetic diagnostics.

Exclusion criteria

* Patient does not understand the Dutch language.

Design outcomes

Primary

Measure	Time frame	Description
Comparing genes to discover unknown functions	Genes will be sequenced and compared, within an expected average of 6 months.	The biobanked bio material and medical data can be used for future research to learn more about the function of genes.

Countries

Netherlands

Contacts

Primary ContactI. Krapels, MD, PhD

ingrid.krapels@mumc.nl+31433875880

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026